| [1] |
Tan YH, Wang ZH, Xu MT, et al. Oral squamous cell carcinomas: State of the field and emerging directions[J]. Int J Oral Sci, 2023, 15(1): 44.
doi: 10.1038/s41368-023-00249-w
pmid: 37736748
|
| [2] |
Hani U, Choudhary VT, Ghazwani M, et al. Nanocarriers for delivery of anticancer drugs: Current developments, challenges, and perspectives[J]. Pharmaceutics, 2024, 16(12): 1527.
doi: 10.3390/pharmaceutics16121527
|
| [3] |
Wu GH, Chen YS, Chen C, et al. Role and mechanisms of exercise therapy in enhancing drug treatment for glioma: A review[J]. Front Immunol, 2025, 16: 1576283.
doi: 10.3389/fimmu.2025.1576283
|
| [4] |
Liu JL, He CS, Tan WZ, et al. Path to bacteriotherapy: From bacterial engineering to therapeutic perspectives[J]. Life Sci, 2024, 352: 122897.
doi: 10.1016/j.lfs.2024.122897
|
| [5] |
Moghimipour E, Abedishirehjin S, Baghbadorani MA, et al. Bacteria and Archaea: A new era of cancer therapy[J]. J Control Release, 2021, 338: 1-7.
doi: 10.1016/j.jconrel.2021.08.019
|
| [6] |
Dhital S, Deo P, Stuart I, et al. Bacterial outer membrane vesicles and host cell death signaling[J]. Trends Microbiol, 2021, 29(12): 1106-1116.
doi: 10.1016/j.tim.2021.04.003
pmid: 34001418
|
| [7] |
Skotland T, Llorente A, Sandvig K. Lipids in extracellular vesicles: What can be learned about membrane structure and function?[J]. Cold Spring Harb Perspect Biol, 2023, 15(8): a041415.
doi: 10.1101/cshperspect.a041415
|
| [8] |
Zou MZ, Li ZH, Bai XF, et al. Hybrid vesicles based on autologous tumor cell membrane and bacterial outer membrane to enhance innate immune response and personalized tumor immunotherapy[J]. Nano Lett, 2021, 21(20): 8609-8618.
doi: 10.1021/acs.nanolett.1c02482
|
| [9] |
Zarepour A, Khosravi A, Yücel Ayten N, et al. Innovative approaches for cancer treatment: Graphene quantum dots for photodynamic and photothermal therapies[J]. J Mater Chem B, 2024, 12(18): 4307-4334.
doi: 10.1039/d4tb00255e
pmid: 38595268
|
| [10] |
Chen JQ, Ning CY, Zhou ZN, et al. Nanomaterials as photothermal therapeutic agents[J]. Prog Mater Sci, 2019, 99: 1-26.
doi: 10.1016/j.pmatsci.2018.07.005
pmid: 30568319
|
| [11] |
Gao Y, Mu MY, Wei YJ, et al. Novel ultrathin ferrous sulfide nanosheets: Towards replacing black phosphorus in anticancer nanotheranostics[J]. Bioact Mater, 2025, 43: 564-578.
doi: 10.1016/j.bioactmat.2024.09.035
pmid: 40115876
|
| [12] |
Wang JJ, Sun ZL, Wang SR, et al. Biodegradable ferrous sulfide-based nanocomposites for tumor theranostics through specific intratumoral acidosis-induced metabolic symbiosis disruption[J]. J Am Chem Soc, 2022, 144(43): 19884-19895.
doi: 10.1021/jacs.2c07669
pmid: 36183257
|
| [13] |
Chen YH, Gu LJ, Ma BH, et al. Photoactivatable metal organic framework for synergistic ferroptosis and photodynamic therapy using 450 nm laser[J]. Chem Eng J, 2023, 454: 140438.
doi: 10.1016/j.cej.2022.140438
|
| [14] |
Zezeski AL, Hamilton LE, Geary TW. Improved evaluation of mitochondrial membrane potential in bovine spermatozoa using JC-1 with flow cytometry[J]. Biol Reprod, 2025, 113(1): 141-153.
doi: 10.1093/biolre/ioaf081
|
| [15] |
Małota K, Student S, Świᶏtek P. Low mitochondrial activity within developing earthworm male germ-line cysts revealed by JC-1[J]. Mitochondrion, 2019, 44: 111-121.
doi: S1567-7249(17)30084-3
pmid: 29398303
|
| [16] |
Chen YN, Hu MR, Wang L, et al. Macrophage M1/M2 polarization[J]. Eur J Pharmacol, 2020, 877: 173090.
doi: 10.1016/j.ejphar.2020.173090
|
| [17] |
Gunassekaran GR, Poongkavithai Vadevoo SM, Baek MC, et al. M1 macrophage exosomes engineered to foster M1 polarization and target the IL-4 receptor inhibit tumor growth by reprogramming tumor-associated macrophages into M1-like macrophages[J]. Biomaterials, 2021, 278: 121137.
doi: 10.1016/j.biomaterials.2021.121137
|
| [18] |
Chen Q, Liu CY, Liu C, et al. Wrapping Porphyromonas gingivalis for tumor microenvironment immunomodulation and photothermal immunotherapy[J]. Nano Today, 2021, 41: 101311.
doi: 10.1016/j.nantod.2021.101311
|
| [19] |
Kawaguchi H, Sakamoto T, Koya T, et al. Quality verification with a cluster-controlled manufacturing system to generate monocyte-derived dendritic cells[J]. Vaccines, 2021, 9(5): 533.
doi: 10.3390/vaccines9050533
|
| [20] |
Moon CY, Belabed M, Park MD, et al. Dendritic cell maturation in cancer[J]. Nat Rev Cancer, 2025, 25(4): 225-248.
doi: 10.1038/s41568-024-00787-3
pmid: 39920276
|
| [21] |
Min H, Qi YQ, Zhang YL, et al. A graphdiyne oxide-based iron sponge with photothermally enhanced tumor-specific Fenton chemistry[J]. Adv Mater, 2020, 32(31): e2000038.
|
| [22] |
Chen Y, Ma Q, Zhang J, et al. Endogenous iron(Ⅱ) self-enriched Fenton nanocatalyst via FTH1 activity inhibition and iron(Ⅲ) reduction for amplified cancer ferroptosis therapy[J]. Mol Pharm, 2025, 22(3): 1568-1583.
doi: 10.1021/acs.molpharmaceut.4c01292
|
| [23] |
Xie CK, Cen D, Ren ZH, et al. FeS@BSA nanoclusters to enable H2S-amplified ROS-based therapy with MRI guidance[J]. Adv Sci (Weinh), 2020, 7(7): 1903512.
|
| [24] |
Jiang H, Guo YD, Yu ZG, et al. Nanocatalytic bacteria disintegration reverses immunosuppression of colorectal cancer[J]. Natl Sci Rev, 2022, 9(11): nwac169.
|
| [25] |
Chen HY, Wang DQ, Liu JH, et al. Augmenting antitumor immune effects through the coactivation of cGAS-STING and NF-κB crosstalk in dendritic cells and macrophages by engineered manganese ferrite nanohybrids[J]. ACS Appl Mater Interfaces, 2025, 17(9): 13375-13390.
doi: 10.1021/acsami.4c18570
|
| [26] |
dos Santos HWG, Bramante BC, Perez MM, et al. Expression profile of IL-2, IL-6, IL-10, and TNF-α in breast tumors[J]. Int J Mol Sci, 2025, 26(16): 7841.
doi: 10.3390/ijms26167841
|